1. Home
2. Networks
3. CCII’s Global Network

CCII’s Global Network
Cancer is a global disease that affects all humans and developing new therapies for cancer is an equally global endeavor. Immune checkpoint inhibitors were first discovered in Japan, but it was global pharmaceutical companies that brought the first anti-PD1 antibodies to market. Our goal at CCII is to become a hub for collaborations with research institutions and companies in Japan and abroad in order to accelerate the translation of new discoveries into new treatments to be delivered to patients. As a research organization, our goal is to collaborate at a global scale and to work with partners in the US, Europe, Asia, Africa, or Oceania. From the outset, we have been building a network with the main research organization in the field of cancer immunotherapy.

---

Bloomberg-Kimmel Institute for Cancer Immunotherapy　

The Bloomberg-Kimmel Institute for Cancer Immunotherapy is a research center under the Sidney Kimmel Comprehensive Cancer Center at John Hopkins University. 
more 

University Medical Center Hamburg-Eppendorf (UKE), Department of Tumor Biology

The Department of Tumor Biology at the UKE Hamburg is a leading research organization focused on basic and translational research in liquid biomarkers.
more

Institut Curie

As a leading life sciences and biophysics research organization, the Institut Curie in Paris is also a pioneer in advanced cancer treatment provided at its own hospital. 
more

Princess Margaret Cancer Centre

The Princess Margaret Cancer Centre, UHN, is the largest integrated cancer center in Canada.
more

The Moores Cancer Center, San Diego Health

The Moores Cancer Center at San Diego Health is one of the leading cancer centers in the US and a particular focus for CCII and Kyoto University, which has a longstanding relationship with the University of California, San Diego.
more

IFOM

IFOM is a cancer research institute focused on the study of cancer formation and development at molecular level founded by the Italian Cancer Research Foundation FIRC.
more

Cancer Science Institute of Singapore (CSI Singapore)

The Cancer Science Institute of Singapore (CSI Singapore) is a University Research Institute at the National University of Singapore (NUS). Officially launched on 15 October 2008, CSI Singapore aims to position Singapore as a global-leader in the field of Biomedical Sciences. Its mission is to better understand the causes of human cancer across Asia, and thereby improve its detection, treatment and prevention for the benefit of the patients. The CSI Singapore’s outstanding researchers and excellent scientific facilities create an energetic environment for ground-breaking research and world-class training. The CSI Singapore is internationally recognized for its innovative research on the biology of cancers prevalent in Asia, and for taking new methods for cancer treatment from the laboratory to the clinic. Through its local and global partnerships, the CSI Singapore works with leading minds from multiple scientific and clinical disciplines, both in academia and in industry.
more